investordatabase.org

Petrichor

petrichorcap.com Direct investor

Petrichor is a healthcare-focused investment platform launched in 2018, spanning company formation through late-stage and commercial growth. It operates through Petrichor Capital Partners, which supports therapeutics, medical technology and diagnostics companies, and Scion Life Sciences, a venture capital fund that founds and builds biotechnology companies.

Petrichor is a venture capital firm headquartered in New York, United States, founded in 2018. It invests directly in companies, from pre-seed to growth, in healthcare, biopharmaceutical, medical technology and diagnostics.

“Petrichor supports world-class healthcare managers and businesses.”

— Petrichor, own website
Layer
Direct investor
Type
Venture capital
Stage
Pre-seed – Growth
Headquarters
New York, United States
Invests in
around the world
Sectors
healthcare, biopharmaceutical, medical technology, diagnostics, therapeutics
Founded
2018

Team, as Petrichor publishes it

  • Tadd Wessel Founder and Managing Partner
  • Patrick Lally Partner
  • Michael Beecham Partner
  • Lucy Burke Senior Associate
  • Thomas Leichner Associate
  • Andrew Davis Associate
  • Paul Sekhri Petrichor Operating Partner
  • Don Hardison Petrichor Operating Partner
  • Samuel Hall, PhD Founder, Managing Partner Scion
  • Aaron Kantoff Founder, Managing Partner Scion
  • Andreas Loew, PhD Partner
  • Megan Blewett Principal

Names and roles exactly as listed on petrichorcap.com. Nothing else about these people is recorded.

Where this comes from

Every fact above was read from a page Petrichor publishes itself. Nothing is taken from third-party databases. Investment activity (deals, co-investors) is not yet recorded.

Is this record wrong or stale? Report a mistake — it reaches us directly, no email address to look up.

Record 14254 · added 2026-10-20 · link last verified 2026-10-21 · confidence medium

Similar investors

Listed under